Skip to main content

Table 4 Neonatal outcomes according to the two GnRH-a protocols before and after propensity score matching

From: The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study

 

Before propensity matching

After propensity matching

Long GnRH-a

Depot GnRH-a

P-value

Long GnRH-a

Depot GnRH-a

P-value

Gestational weeks

38.08 (1.89)

37.93 (2.05)

0.121

38.17 (1.76)

38.03(1.98)

0.270

Birth weights(g)

3133.28 (572.87)

3042.07 (594.01)

0.002

3165.93 (564.08)

3059.98 (587.38)

0.004

Fetuses delivered, n (%)

  

0.002

  

0.056

 Single

449/581 (77.28)

1069/1517 (70.47)

 

367/467 (78.59)

374/511 (73.19)

 

 Twins

132/581 (22.72)

448/1517 (29.53)

 

100/467 (21.41)

137/511 (26.81)

 

Fetus's sex, n (%)

  

0.026

  

0.371

 A boy

251/581 (43.20)

583/1517 (38.43)

 

198/467 (41.40)

201/511 (39.33)

 

 A girl

198/581 (34.08)

486/1517 (32.04)

 

169/467 (36.19)

173/511 (33.86)

 

 Two boys

40/581 (6.88)

143/1517 (9.43)

 

31/467 (6.64)

40/511 (7.83)

 

 Two girls

24/581 (4.13)

97/1517(6.39)

 

22/467 (4.71)

35/511 (6.85)

 

 A boy and a girl

68/581 (11.70)

208/1517 (13.71)

 

47/467 (10.06)

62/511 (12.13)

 

Fetal malformation rate (%)

5/581 (0.86)

16/1517 (1.05)

0.694

4/467 (0.86)

9/511 (1.76)

0.147

  1. Date: mean (SD) or (%) (no./total no.)
  2. GnRH-a gonadotropin-releasing hormone agonist